Spanish Red Biotech Pipeline

MSD

Pembrolizumab/Lenvatinib

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Indication: Lenvatinib plus Pembrolizumab for Second Line Therapy of Advanced melanoma post anti-PD1b inhibitor
Phase: 2Phase II in Spain, 1Phase I